Adjuvant S-1 extends OS in biliary tract cancers

被引:0
|
作者
Romero, Diana
机构
[1] Nature Reviews Clinical Oncology,
关键词
D O I
10.1038/s41571-023-00738-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [31] Phase 2 Trial of Adjuvant Chemotherapy With S-1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
    Seita, Kazuaki
    Ebata, Tomoki
    Mizuno, Takashi
    Maeda, Atsuyuki
    Yamaguchi, Ryuzo
    Kurumiya, Yasuhiro
    Sakamoto, Eiji
    Hiramatsu, Kazuhiro
    Ando, Masahiko
    Nagino, Masato
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2348 - 2356
  • [32] Continuation rather than early induction in S-1 adjuvant chemotherapy and prognosis in patients after biliary tract cancer resection.
    Hayashida, Kotaro
    Adachi, Tomohiko
    Imamura, Hajime
    Yamashita, Manpei
    Tetsuo, Hanako
    Matsushima, Hajime
    Hara, Takanobu
    Soyama, Akihiko
    Kanetaka, Kengo
    Eguchi, Susumu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 474 - 474
  • [33] Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT)
    Ikeda, Masafumi
    Nakachi, Kohei
    Konishi, Masaru
    Nomura, Shogo
    Katayama, Hiroshi
    Kataoka, Tomoko
    Uesaka, Katsuhiko
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Wada, Hiroshi
    Shimada, Kazuaki
    Takahashi, Yu
    Nakagohri, Toshio
    Gotoh, Kunihito
    Kamata, Ken
    Shimizu, Yasuhiro
    Ueno, Makoto
    Ishii, Hiroshi
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [34] Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study
    Gao, Huan
    Tian, Tao
    Li, Suoni
    Zhang, Yinbin
    Fu, Xiao
    Zheng, Xiaoqiang
    Liu, Na
    Jiang, Aimin
    Ren, Mengdi
    Zhang, Xiaoni
    Liang, Xuan
    Ruan, Zhiping
    Geng, Zhimin
    Yao, Yu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 889 - 898
  • [35] Feasibility and potential benefits of adjuvant chemotherapy with S-1 in patients with curative resected advanced biliary tract cancer: A multicenter trial.
    Toyoki, Yoshikazu
    Ishido, Keinosuke
    Kudo, Daisuke
    Kimura, Norihisa
    Wakiya, Taiichi
    Umehara, Yutaka
    Tohyama, Shigeru
    Endoh, Masaaki
    Tateoka, Hiroshi
    Ohishi, Susumu
    Hakamada, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Gemcitabine plus cisplatin and S-1 for biliary tract cancer: a single institute analysis
    Maeda, Osamu
    Shimokata, Tomoya
    Mizutani, Takefumi
    Inoue, Megumi
    Matsuoka, Ayumu
    Ota, Akiko
    Mizuno, Takashi
    Ebata, Tomoki
    Nagino, Masato
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2017, 28 : 50 - 50
  • [37] Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
    Inoue, Hiroto
    Todaka, Akiko
    Yamazaki, Kentaro
    Fushiki, Kunihiro
    Shirasu, Hiromichi
    Kawakami, Takeshi
    Tsushima, Takahiro
    Hamauchi, Satoshi
    Yokota, Tomoya
    Machida, Nozomu
    Fukutomi, Akira
    Onozawa, Yusuke
    Andoh, Akira
    Yasui, Hirofumi
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1399 - 1404
  • [38] Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Rhodin, Kristen E.
    Liu, Annie
    Bartholomew, Alex
    Kramer, Ryan
    Parameswaran, Anika
    Uronis, Hope
    Strickler, John
    Hsu, David
    Morse, Michael A.
    Shah, Kevin N. N.
    Herbert, Garth
    Zani, Sabino
    Nussbaum, Daniel P.
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (8) : 4824 - 4825
  • [39] ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers
    Dee, Edward Christopher
    Freret, Morgan E.
    Wo, Jennifer Y.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 5173 - 5174
  • [40] ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers
    Edward Christopher Dee
    Morgan E. Freret
    Jennifer Y. Wo
    Annals of Surgical Oncology, 2020, 27 : 5173 - 5174